Network News

The Parkinson Foundation has awarded three Innovation Prizes for 2026, including—for the first time—the Manfred Moggert-Kemper Prevention Prize. Prof. Dr. Chi Wang Ip and Assistant Professor Dr. Rhonda McFleder from the Department of Neurology at the University Hospital of Würzburg (UKW), as well as Prof. Dr. Mathias Munschauer from the University Hospital of Heidelberg (UKHD), […]

Do patients recover more quickly after colorectal cancer surgery if they have previously completed a structured preparatory program? Researchers at Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital are investigating this question in the newly launched PREHAB-PEER study. The Federal Ministry of Research, Technology, and Space is funding the project with approximately 3.45 million […]

Immunoassay development used to just mean getting a classic plate-based ELISA up and running. Today, that “standard” ELISA has exploded into many antibody pair-based formats, from homogeneous TR‑FRET assays to multiplexed MSD or Luminex panels—each with its own advantages and pitfalls. The data these assays generate is more robust than ever, but so is the […]

Basel, Switzerland, 3 November 2026 – Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs. The acquisition expands […]

Researchers at Experimentica have demonstrated that human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE) cells provide a highly relevant in vitro model for studying oxidative stress-related retinal diseases, including age-related macular degeneration (AMD). The study showed that these cells closely resemble native human RPE tissue both morphologically and functionally, making them a valuable platform […]

Researchers at the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have discovered a group of particularly long-lived blood stem cells in mice. These cells remain in a dormant state for an exceptionally long time while retaining their ability to generate new blood cells. This newly discovered cell population may be responsible […]

One of the reasons for the high aggressiveness of glioblastomas is their remarkable adaptability. A team led by scientists from the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), HITBR*, and the Wellcome Sanger Institute, Cambridge, now describes in Nature how glioblastoma cells switch between different states. At the same time, the […]

Roberto Würth, Tasneem Cheytan, Paul Schwerd-Kleine, Ewgenija Gutjahr, Elisa Donato, Verena Thewes, Beatrice Charlotte Tröster, Theresa Mulholland, Torsten Müller, Daria Doncevic, Laura L Michel, Celina V Wagner, Polina Kozyulina, Mario Hlevnjak, Marc Zapatka, Julia Bulkescher, Rebecca Weber, Sarah-Jane Neuberth, Vera Thiel, Thilo Miersch, Michael Scherer, Johannes Betge, Jeroen Krijgsveld, Carl Herrmann, Peter Lichter, Andreas Schneeweiss, Martin R Sprick, Andreas Trumpp  Neuroendocrine differentiation (NED) promotes lineage plasticity and therapy resistance in prostate and lung cancers. Here we identify NED as a route of […]

Why do certain congenital kidney disorders vary so widely in severity among affected individuals? Can AI improve breast cancer diagnostics? These are the questions being addressed in current projects by two early-career researchers at the Heidelberg Faculty of Medicine at Heidelberg University. The Else Kröner-Fresenius Stiftung is supporting the research of Dr. Caroline M. Kolvenbach […]